The mission of the Masonic Cancer Center (MCC) Flow Cytometry Shared Resource (FCSR) is to provide comprehensive state-of-the-art services and training in all aspects of flow cytometry to MCC personnel in a cost-effective manner. The FCSR has facilities in both the Masonic Cancer Research Building (MCRB) and the Cancer and Cardiovascular Research Building (CCRB). Several years ago, the FCSR was one of several independent flow cytometry facilities in the Academic Health Center (AHC) at the University of Minnesota; each was administered by a separate Center, Department, or Institute. The directors of these facilities and AHC leadership decided to merge the flow cytometry facilities under one administrative umbrella with centralized financial support from the AHC. This new University Flow Cytometry Resource (UFCR) provided an economy of scale, more funds to purchase equipment, and uniformity of support among the AHC centers and institutes that require flow cytometry equipment and expertise. It also allowed MCC researchers not housed in MCRB or CCRB to access flow cytometry facilities other than FCSR and still receive an MCC subsidy for equipment use. The FCSR is the largest of the 4 members in the UFCR consortium in terms of usage (approximately 80% of billed hours) and instrumentation (7 of 10 flow cytometers, 2 of 3 cell sorters, and 2 of 2 data analysis work stations). The FCSR Director of Daily Operations is Mr. Paul Champoux; he is supported by 3 full-time personnel, AHC administration, and a 5-member Board of Scientific Directors. Dr. Christopher Pennell serves on this Board as the Scientific Director of Flow Cytometry for MCC. He has oversight for all cancer-related projects that use FCSR, and decisions regarding FCSR or any of the other 3 UFCR members requires Dr. Pennell's agreement; this ensures that FCSR, and UFCR as a whole, meet the flow cytometry needs of MCC researchers. The FCSR regularly partners with industry leaders to test and adopt new flow cytometry technologies, keeping it at the cutting-edge of flow cytometry. As a result, the FCSR has had instrumentation retrofitted with new technologies prior to commercial availability. These advancements have benefitted customers and provided tools for the faculty to remain competitive with their peers, all at very low expense.
The specific aims for the next 5 years are to 1) provide MCC researchers with 24/7 access to advanced flow cytometric instruments; 2) aid MCC researchers in the design of flow cytometry experiments, data acquisition, and data interpretation; 3) educate MCC researchers regarding the principles of flow cytometry and train users on self-service analyzers; 4) beta-test new reagents and equipment and continually upgrade equipment; and 5) share cutting-edge advancements in flow cytometry with MCC researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA077598-23
Application #
10086441
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-06-01
Project End
2024-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
23
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Ma, Bin; Zarth, Adam T; Carlson, Erik S et al. (2018) Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 31:48-57
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891
Lee, Hak Rae; Leslie, Faith; Azarin, Samira M (2018) A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2. J Biol Eng 12:12
Yang, Libang; Herrera, Jeremy; Gilbertsen, Adam et al. (2018) IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. Am J Physiol Lung Cell Mol Physiol 314:L127-L136
Regan Anderson, Tarah M; Ma, Shihong; Perez Kerkvliet, Carlos et al. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Mol Cancer Res 16:1761-1772
Grzywacz, Bartosz; Moench, Laura; McKenna Jr, David et al. (2018) Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control. J Immunother :
Santiago, Victor; Lazaryan, Aleksandr; McClune, Brian et al. (2018) Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome. Leuk Lymphoma 59:958-966
Guo, Jingshu; Villalta, Peter W; Weight, Christopher J et al. (2018) Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry. Chem Res Toxicol :
Boatman, Jeffrey A; Vock, David M; Koopmeiners, Joseph S et al. (2018) Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics 19:103-118
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples. Br J Haematol 182:887-894

Showing the most recent 10 out of 1013 publications